Cargando…
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
Major depressive disorder (MDD) is a chronic, generally episodic and debilitating disease that affects an estimated 300 million people worldwide, but its pathogenesis is poorly understood. The heritability estimate of MDD is 30–40%, suggesting that genetics alone do not account for most of the risk...
Autores principales: | Yuan, Minlan, Yang, Biao, Rothschild, Gerson, Mann, J. John, Sanford, Larry D., Tang, Xiangdong, Huang, Canhua, Wang, Chuang, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465587/ https://www.ncbi.nlm.nih.gov/pubmed/37644009 http://dx.doi.org/10.1038/s41392-023-01519-z |
Ejemplares similares
-
Epigenetic Modifications of Major Depressive Disorder
por: Saavedra, Kathleen, et al.
Publicado: (2016) -
Epigenetic prediction of major depressive disorder
por: Barbu, Miruna C., et al.
Publicado: (2020) -
Clinical Relevance of Vilazodone Treatment in Patients With Major Depressive Disorder: Categorical Improvement in Symptoms
por: Culpepper, Larry, et al.
Publicado: (2014) -
Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
por: Seo, Rubo J., et al.
Publicado: (2010) -
The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder
por: Czarny, Piotr, et al.
Publicado: (2021)